{"transactions":[{"id":697845,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-04T15:55:47.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan, subject to shareholder approval."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001493152-26-035950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000149315226035950/ownership.xml","form_type":"4"}},{"id":3149451,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-14T20:07:22.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-11","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001103021-20-000085","document":"wf-form4_158948682328123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000085/wf-form4_158948682328123.xml","form_type":"4"}},{"id":3149450,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T20:07:22.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":628038,"source":{"system":"sec-edgar","filing":"0001103021-20-000085","document":"wf-form4_158948682328123.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000085/wf-form4_158948682328123.xml","form_type":"4"}},{"id":3156826,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:06:32.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":11250,"price":4.53,"value":50962.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 6, 2020, the Reporting Person sold an aggregate of 11,250 shares of the Issuer's Common Stock at a weighted average price of $4.53 per share. The highest sale price for the Common Stock was $4.66 per share and the lowest sale price was $4.44 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":605538,"source":{"system":"sec-edgar","filing":"0001103021-20-000075","document":"wf-form4_158896837397701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000075/wf-form4_158896837397701.xml","form_type":"4"}},{"id":3161870,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-05T20:06:39.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":16000,"price":4.45,"value":71200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 4, 2020, the Reporting Person sold an aggregate of 16,000 shares of the Issuer's Common Stock at a weighted average price of $4.45 per share. The highest sale price for the Common Stock was $4.56 per share and the lowest sale price was $4.39 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":616788,"source":{"system":"sec-edgar","filing":"0001103021-20-000064","document":"wf-form4_158870918252713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000064/wf-form4_158870918252713.xml","form_type":"4"}},{"id":3171944,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-22T20:18:41.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":20000,"price":4.22,"value":84400.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 20, 2020, the Reporting Person sold an aggregate of 20,000 shares of the Issuer's Common Stock at a weighted average price of $4.22 per share. The highest sale price for the Common Stock was $4.29 per share and the lowest sale price was $4.15 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":632788,"source":{"system":"sec-edgar","filing":"0001103021-20-000058","document":"wf-form4_158758670274343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000058/wf-form4_158758670274343.xml","form_type":"4"}},{"id":3203117,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-03-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203116,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended, (the EIP)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended, (the EIP)."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-03-19","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203115,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-17","kind":"sale","acquired":false,"shares":30500,"price":3.63,"value":110715.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F7","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On March 17, 2020, the Reporting Person sold an aggregate of 30,500 shares of the Issuer's Common Stock at a weighted average price of $3.63 per share. The highest sale price for the Common Stock was $3.81 per share and the lowest sale price was $3.39 per share."}],"balance_after":656072,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203114,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":38750,"price":3.6,"value":139500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F7","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On March 16, 2020, the Reporting Person sold an aggregate of 38,750 shares of the Issuer's Common Stock at a weighted average price of $3.60 per share. The highest sale price for the Common Stock was $3.72 per share and the lowest sale price was $3.46 per share."}],"balance_after":686572,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203113,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":18284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of 18,284 RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of 18,284 RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."}],"balance_after":725322,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203112,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2021 subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2021 subject to certain performance measures."}],"balance_after":700470,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203111,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2021."}],"balance_after":688754,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203110,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures."}],"balance_after":673754,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3203109,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T20:18:35.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended, (the EIP)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended, (the EIP)."}],"balance_after":611254,"source":{"system":"sec-edgar","filing":"0001103021-20-000052","document":"wf-form4_158456269796322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000052/wf-form4_158456269796322.xml","form_type":"4"}},{"id":3292559,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T00:21:17.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":8000,"price":5.31,"value":42480.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 3, 2020, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $5.31 per share. The highest sale price for the Common Stock was $5.38 per share and the lowest sale price was $5.12 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":548754,"source":{"system":"sec-edgar","filing":"0001103021-20-000026","document":"wf-form4_158086206019120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000026/wf-form4_158086206019120.xml","form_type":"4"}},{"id":3324105,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T21:23:22.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":8000,"price":6.1,"value":48800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 2, 2020, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $6.10 per share. The highest sale price for the Common Stock was $6.30 per share and the lowest sale price was $5.86 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":556754,"source":{"system":"sec-edgar","filing":"0001103021-20-000002","document":"wf-form4_157808658444249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302120000002/wf-form4_157808658444249.xml","form_type":"4"}},{"id":3329229,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-12-31T21:20:54.000Z","date":"2019-12-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A amends the Reporting Person's Form 4 filed on December 30, 2019 to reflect that the shares of Common Stock were sold following the automatic exercise of the Reporting Person's stock options (right to buy)."}],"balance_after":0,"derivative":{"exercise_price":1.96,"exercise_date":"2012-02-12","expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001103021-19-000061","document":"wf-form4a_157782723730257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000061/wf-form4a_157782723730257.xml","form_type":"4/A","original_submission_date":"2019-12-31"}},{"id":3329228,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-31T21:20:54.000Z","date":"2019-12-26","kind":"sale","acquired":false,"shares":10000,"price":7,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A amends the Reporting Person's Form 4 filed on December 30, 2019 to reflect that the shares of Common Stock were sold following the automatic exercise of the Reporting Person's stock options (right to buy)."}],"balance_after":564754,"source":{"system":"sec-edgar","filing":"0001103021-19-000061","document":"wf-form4a_157782723730257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000061/wf-form4a_157782723730257.xml","form_type":"4/A","original_submission_date":"2019-12-31"}},{"id":3329227,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-31T21:20:54.000Z","date":"2019-12-26","kind":"exercise","acquired":true,"shares":10000,"price":1.96,"value":19600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4/A amends the Reporting Person's Form 4 filed on December 30, 2019 to reflect that the shares of Common Stock were sold following the automatic exercise of the Reporting Person's stock options (right to buy)."}],"balance_after":574754,"source":{"system":"sec-edgar","filing":"0001103021-19-000061","document":"wf-form4a_157782723730257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000061/wf-form4a_157782723730257.xml","form_type":"4/A","original_submission_date":"2019-12-31"}},{"id":3329877,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-30T22:40:51.000Z","date":"2019-12-26","kind":"sale","acquired":false,"shares":10000,"price":7,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 26, 2019, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's Common Stock at a weighted average price of $7.00 per share. The highest sale price for the Common Stock was $7.01 per share and the lowest sale price was $7.00 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":554754,"source":{"system":"sec-edgar","filing":"0001103021-19-000059","document":"wf-form4_157774563169597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000059/wf-form4_157774563169597.xml","form_type":"4"}},{"id":3352934,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-04T21:13:09.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":8000,"price":6.86,"value":54880.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 2, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $6.86 per share. The highest sale price for the Common Stock was $6.96 per share and the lowest sale price was $6.71 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":564754,"source":{"system":"sec-edgar","filing":"0001103021-19-000048","document":"wf-form4_157549397191205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000048/wf-form4_157549397191205.xml","form_type":"4"}},{"id":3380689,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-05T21:31:31.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":8000,"price":5.83,"value":46640.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On November 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $5.83 per share. The highest sale price for the Common Stock was $5.94 per share and the lowest sale price was $5.72 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":572754,"source":{"system":"sec-edgar","filing":"0001103021-19-000027","document":"wf-form4_157298947575370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000027/wf-form4_157298947575370.xml","form_type":"4"}},{"id":3385528,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-10-30T20:33:56.000Z","date":"2019-10-28","kind":"exercise","acquired":false,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.47,"exercise_date":"2011-07-20","expiration_date":"2021-07-20","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001103021-19-000025","document":"wf-form4_157246762155802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000025/wf-form4_157246762155802.xml","form_type":"4"}},{"id":3385527,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T20:33:56.000Z","date":"2019-10-28","kind":"sale","acquired":false,"shares":32500,"price":6,"value":195000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":580754,"source":{"system":"sec-edgar","filing":"0001103021-19-000025","document":"wf-form4_157246762155802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000025/wf-form4_157246762155802.xml","form_type":"4"}},{"id":3385526,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-30T20:33:56.000Z","date":"2019-10-28","kind":"exercise","acquired":true,"shares":32500,"price":3.47,"value":112775.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":613254,"source":{"system":"sec-edgar","filing":"0001103021-19-000025","document":"wf-form4_157246762155802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000025/wf-form4_157246762155802.xml","form_type":"4"}},{"id":3392366,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2019-10-17T21:26:49.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":2.26,"exercise_date":"2010-07-21","expiration_date":"2020-07-21","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001103021-19-000020","document":"wf-form4_157134757985548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000020/wf-form4_157134757985548.xml","form_type":"4"}},{"id":3392365,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T21:26:49.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":32500,"price":5,"value":162500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"On October 15, 2019, the Reporting Person sold an aggregate of 32,500 shares of the Issuer's Common Stock at a weighted average price of $5.00 per share. The highest sale price for the Common Stock was $5.02 per share and the lowest sale price was $5.00 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":580754,"source":{"system":"sec-edgar","filing":"0001103021-19-000020","document":"wf-form4_157134757985548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000020/wf-form4_157134757985548.xml","form_type":"4"}},{"id":3392364,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T21:26:49.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":32500,"price":2.26,"value":73450.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":613254,"source":{"system":"sec-edgar","filing":"0001103021-19-000020","document":"wf-form4_157134757985548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000020/wf-form4_157134757985548.xml","form_type":"4"}},{"id":3399107,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T20:11:58.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":8000,"price":4.34,"value":34720.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.34 per share. The highest sale price for the Common Stock was $4.40 per share and the lowest sale price was $4.28 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":580754,"source":{"system":"sec-edgar","filing":"0001103021-19-000017","document":"wf-form4_157013349492572.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000017/wf-form4_157013349492572.xml","form_type":"4"}},{"id":3423755,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-04T20:08:10.000Z","date":"2019-09-03","kind":"sale","acquired":false,"shares":8000,"price":4.29,"value":34320.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 3, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.29 per share. The highest sale price for the Common Stock was $4.35 per share and the lowest sale price was $4.19 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":588754,"source":{"system":"sec-edgar","filing":"0001103021-19-000011","document":"wf-form4_156762767454014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000110302119000011/wf-form4_156762767454014.xml","form_type":"4"}},{"id":3449773,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T20:06:16.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":8000,"price":3.82,"value":30560.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $3.82 per share. The highest sale price for the Common Stock was $3.94 per share and the lowest sale price was $3.67 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":596754,"source":{"system":"sec-edgar","filing":"0001628280-19-009862","document":"wf-form4_156477635945465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000162828019009862/wf-form4_156477635945465.xml","form_type":"4"}},{"id":3468946,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T22:00:21.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":8000,"price":4.68,"value":37440.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.68 per share. The highest sale price for the Common Stock was $4.75 per share and the lowest sale price was $4.63 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":604754,"source":{"system":"sec-edgar","filing":"0000899243-19-019205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319019205/doc4.xml","form_type":"4"}},{"id":3500985,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T22:00:16.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":8000,"price":4.32,"value":34560.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On June 3, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.32 per share. The highest sale price for the Common Stock was $4.42 per share and the lowest sale price was $4.26 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":612754,"source":{"system":"sec-edgar","filing":"0000899243-19-015636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319015636/doc4.xml","form_type":"4"}},{"id":3532022,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-10T22:02:10.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended . The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended . The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended . The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."}],"balance_after":22500,"derivative":{"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-013105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319013105/doc4.xml","form_type":"4"}},{"id":3532021,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T22:02:10.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended . The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."}],"balance_after":620754,"source":{"system":"sec-edgar","filing":"0000899243-19-013105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319013105/doc4.xml","form_type":"4"}},{"id":3540569,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T22:00:25.000Z","date":"2019-05-01","kind":"sale","acquired":false,"shares":8000,"price":4.77,"value":38160.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.77 per share. The highest sale price for the Common Stock was $4.85 per share and the lowest sale price was $4.69 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":598254,"source":{"system":"sec-edgar","filing":"0000899243-19-012060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319012060/doc4.xml","form_type":"4"}},{"id":3552210,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-04-19T22:00:17.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options (\"options\") were issued to the Reporting Person on April 17, 2019, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 11,250 options vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, and (ii) 11,250 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. The exercise price of the options is the volume-weighted average price of the Issuer's Common Stock for the 30-day period ending April 16, 2019."}],"balance_after":22500,"derivative":{"exercise_price":4.96,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-010939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319010939/doc4.xml","form_type":"4"}},{"id":3552209,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-04-19T22:00:17.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on April 17, 2019, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 22,500 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, and (ii) 22,500 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020."}],"balance_after":45000,"derivative":{"exercise_price":0,"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-19-010939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319010939/doc4.xml","form_type":"4"}},{"id":3566011,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T22:00:32.000Z","date":"2019-04-01","kind":"sale","acquired":false,"shares":8000,"price":5.19,"value":41520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $5.19 per share. The highest sale price for the Common Stock was $5.34 per share and the lowest sale price was $5.12 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":606254,"source":{"system":"sec-edgar","filing":"0000899243-19-009828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319009828/doc4.xml","form_type":"4"}},{"id":3581956,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":false,"shares":9757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2019-03-20","underlying":"Common Stock","underlying_shares":9757},"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581955,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-03-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581954,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021."}],"balance_after":30000,"derivative":{"exercise_price":0,"expiration_date":"2021-03-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581953,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-03-19","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581952,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020."}],"balance_after":62500,"derivative":{"exercise_price":0,"expiration_date":"2020-03-19","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581951,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-21","kind":"sale","acquired":false,"shares":71690,"price":5.21,"value":373504.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The shares of Common Stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"security","element":"securityTitle","label":"F8","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On March 21, 2019, the Reporting Person sold an aggregate of 71,690 shares of the Common Stock at a weighted average price of $5.21 per share. The highest sale price for the Common Stock was $5.33 per share and the lowest sale price was $5.04 per share."}],"balance_after":614254,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581950,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":9757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."}],"balance_after":685944,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581949,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 Performance RSUs granted to the Reporting Person on February 18, 2018 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."}],"balance_after":676187,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581948,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"exercise","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 15,000 of RSUs granted to the Reporting Person on February 18, 2018 under the EIP. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020 and March 2021."}],"balance_after":661187,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581947,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 Performance RSUs granted to the Reporting Person on February 6, 2017 under the EIP, subject to certain performance measures. The remainder of the PRSUs under this grant will vest after the first open window upon the filing of the Company's Annual Report in March 2020 subject to certain performance measures."}],"balance_after":646187,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3581946,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T22:01:50.000Z","date":"2019-03-20","kind":"exercise","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 62,500 of Restricted Stock Units (RSUs) granted to the Reporting Person on February 6, 2017 under the Issuer's 2011 Equity Incentive Plan, as amended (the EIP). The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Annual Report in March 2020."}],"balance_after":583687,"source":{"system":"sec-edgar","filing":"0000899243-19-008814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319008814/doc4.xml","form_type":"4"}},{"id":3624099,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-01T23:43:05.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2019-03-01","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000899243-19-005533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319005533/doc4.xml","form_type":"4"}},{"id":3624098,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T23:43:05.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":23000,"price":5.07,"value":116610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 1, 2019, the Reporting Person sold an aggregate of 23,000 shares of the Issuer's Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.20 per share and the lowest sale price was $4.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":521187,"source":{"system":"sec-edgar","filing":"0000899243-19-005533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319005533/doc4.xml","form_type":"4"}},{"id":3624097,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T23:43:05.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":544187,"source":{"system":"sec-edgar","filing":"0000899243-19-005533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319005533/doc4.xml","form_type":"4"}},{"id":3678139,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-05T00:28:54.000Z","date":"2019-02-01","kind":"sale","acquired":false,"shares":8000,"price":4.6,"value":36800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 1, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $4.60 per share. The highest sale price for the Common Stock was $4.68 per share and the lowest sale price was $4.52 per share."}],"balance_after":498187,"source":{"system":"sec-edgar","filing":"0000899243-19-002533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319002533/doc4.xml","form_type":"4"}},{"id":3705335,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T23:01:23.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":8000,"price":3.64,"value":29120.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 2, 2019, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $3.64 per share. The highest sale price for the Common Stock was $3.75 per share and the lowest sale price was $3.54 per share."}],"balance_after":506187,"source":{"system":"sec-edgar","filing":"0000899243-19-000559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924319000559/doc4.xml","form_type":"4"}},{"id":3744508,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-04T23:00:24.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":8000,"price":3.72,"value":29760.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 3, 2018, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $3.72 per share. The highest sale price for the Common Stock was $3.78 per share and the lowest sale price was $3.60 per share."}],"balance_after":514187,"source":{"system":"sec-edgar","filing":"0000899243-18-030074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318030074/doc4.xml","form_type":"4"}},{"id":3776906,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T22:00:25.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":8000,"price":3.84,"value":30720.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On November 1, 2018, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $3.84 per share. The highest sale price for the Common Stock was $3.93 per share and the lowest sale price was $3.70 per share."}],"balance_after":522187,"source":{"system":"sec-edgar","filing":"0000899243-18-028048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318028048/doc4.xml","form_type":"4"}},{"id":3799255,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T22:00:22.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":8000,"price":2.75,"value":22000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 1, 2018, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $2.75 per share. The highest sale price for the Common Stock was $2.83 per share and the lowest sale price was $2.71 per share."}],"balance_after":530187,"source":{"system":"sec-edgar","filing":"0000899243-18-026093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318026093/doc4.xml","form_type":"4"}},{"id":3816120,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"grant","acquired":false,"shares":53438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the performance-based RSUs (\"Performance RSUs\") granted to the Reporting Person on February 6, 2017 under the Plan subject to certain performance measures. The remainder of the Performance RSUs under this grant will vest, in equal amounts, but subject to certain performance measures, after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-09-13","expiration_date":"2018-09-13","underlying":"Common Stock","underlying_shares":53438},"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816119,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 6, 2017 under the Plan. Pursuant to a deferral, these RSUs vested on September 13, 2018. The remainder of the RSUs under this grant will vest in equal portions after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020."}],"balance_after":125000,"derivative":{"exercise_price":0,"exercise_date":"2018-09-13","expiration_date":"2020-02-06","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816118,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"exercise","acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest on March 1, 2019."}],"balance_after":46000,"derivative":{"exercise_price":0,"exercise_date":"2018-09-13","expiration_date":"2019-03-01","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816117,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"grant","acquired":false,"shares":6806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person in connection with the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan. Pursuant to a deferral, these RSUs vested on September 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-09-13","expiration_date":"2018-09-13","underlying":"Common Stock","underlying_shares":6806},"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816116,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-12","kind":"exercise","acquired":false,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 133,333 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 23, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on September 12, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-09-12","expiration_date":"2018-09-12","underlying":"Common Stock","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816115,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"sale","acquired":false,"shares":84372,"price":2.84,"value":239616.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On September 13, 2018, the Reporting Person sold an aggregate of 84,372 shares of the Issuer's Common Stock at a weighted average price of $2.84 per share. The highest sale price for the Common Stock was $2.90 per share and the lowest sale price was $2.90 per share."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":538187,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816114,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"grant","acquired":true,"shares":53438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the performance-based RSUs (\"Performance RSUs\") granted to the Reporting Person on February 6, 2017 under the Plan subject to certain performance measures. The remainder of the Performance RSUs under this grant will vest, in equal amounts, but subject to certain performance measures, after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020."}],"balance_after":622559,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816113,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 6, 2017 under the Plan. Pursuant to a deferral, these RSUs vested on September 13, 2018. The remainder of the RSUs under this grant will vest in equal portions after the first open window upon the filing of the Company's Annual Report in March 2019 and March 2020."}],"balance_after":569121,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816112,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"exercise","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest on March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest on March 1, 2019."}],"balance_after":506621,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816111,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-13","kind":"grant","acquired":true,"shares":6806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person in connection with the vesting of RSUs granted to the Reporting Person under the Issuer's Long-Term Incentive Plan. Pursuant to a deferral, these RSUs vested on September 13, 2018."}],"balance_after":460621,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816110,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":66667,"price":2.83,"value":188667.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 12, 2018, the Reporting Person sold an aggregate of 66,667 shares of the Issuer's Common Stock at a weighted average price of $2.83 per share. The highest sale price for the Common Stock was $2.85 per share and the lowest sale price was $2.80 per share."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":453815,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3816109,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T22:00:41.000Z","date":"2018-09-12","kind":"exercise","acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 133,333 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 23, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 133,333 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 23, 2015 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on September 12, 2018."}],"balance_after":520482,"source":{"system":"sec-edgar","filing":"0000899243-18-024561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318024561/doc4.xml","form_type":"4"}},{"id":3837424,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-21T21:30:46.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":8000,"price":2.79,"value":22320.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F3","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 17, 2018, the Reporting Person sold an aggregate of 8,000 shares of the Issuer's Common Stock at a weighted average price of $2.79 per share. The highest sale price for the Common Stock was $2.85 per share and the lowest sale price was $2.75 per share."}],"balance_after":387149,"source":{"system":"sec-edgar","filing":"0000899243-18-022886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318022886/doc4.xml","form_type":"4"}},{"id":3882544,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-06-27T23:32:07.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.01,"exercise_date":"2008-07-24","expiration_date":"2018-07-24","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000899243-18-018489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318018489/doc4.xml","form_type":"4"}},{"id":3882543,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T23:32:07.000Z","date":"2018-06-25","kind":"tax_withholding","acquired":false,"shares":27525,"price":3.1,"value":85327.5,"ownership":{"direct":true},"balance_after":395149,"source":{"system":"sec-edgar","filing":"0000899243-18-018489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318018489/doc4.xml","form_type":"4"}},{"id":3882542,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T23:32:07.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":37500,"price":2.01,"value":75375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares through a cashless exercise under the Issuer's Amended and Restated 2001 Incentive Plan. The Reporting Person exercised a total of 37,500 options and received 9,975 shares of common stock."}],"balance_after":422674,"source":{"system":"sec-edgar","filing":"0000899243-18-018489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318018489/doc4.xml","form_type":"4"}},{"id":4003935,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-08","kind":"exercise","acquired":false,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on March 8, 2018. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on September 12, 2018."}],"balance_after":133333,"derivative":{"exercise_price":0,"exercise_date":"2018-03-08","expiration_date":"2018-09-12","underlying":"Common Stock","underlying_shares":133333},"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003934,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-07","kind":"exercise","acquired":false,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 13, 2018 and (ii) March 1, 2019."}],"balance_after":92000,"derivative":{"exercise_price":0,"exercise_date":"2018-03-07","expiration_date":"2019-03-01","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003933,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-07","kind":"exercise","acquired":false,"shares":48418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 48,418 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on March 7, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-03-07","expiration_date":"2018-03-07","underlying":"Common Stock","underlying_shares":48418},"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003932,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":66666,"price":2.14,"value":142665.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On March 8, 2018, the Reporting Person sold an aggregate of 66,666 shares of the Issuer's Common Stock at a weighted average price of $2.14 per share. The highest sale price for the Common Stock was $2.18 per share and the lowest sale price was $2.10 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":385174,"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003931,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-08","kind":"exercise","acquired":true,"shares":133333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on March 8, 2018. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on September 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on March 8, 2018. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on September 12, 2018."}],"balance_after":451840,"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003930,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-07","kind":"sale","acquired":false,"shares":47210,"price":2.13,"value":100557.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On March 7, 2018, the Reporting Person sold an aggregate of 47,210 shares of the Issuer's Common Stock at a weighted average price of $2.13 per share. The highest sale price for the Common Stock was $2.20 per share and the lowest sale price was $2.10 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":318507,"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003929,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-07","kind":"exercise","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 13, 2018 and (ii) March 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 29, 2016 under the Plan. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 13, 2018 and (ii) March 1, 2019."}],"balance_after":365717,"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4003928,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T23:01:16.000Z","date":"2018-03-07","kind":"exercise","acquired":true,"shares":48418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 48,418 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on March 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 48,418 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on March 7, 2018."}],"balance_after":319717,"source":{"system":"sec-edgar","filing":"0000899243-18-006982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318006982/doc4.xml","form_type":"4"}},{"id":4037743,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-02-24T00:21:37.000Z","date":"2018-02-18","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The RSUs were issued to the Reporting Person on February 18, 2018, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and will vest as follows: (i) one-third vests on the first open trading window of 2019; (ii) one-third vests on the date of the first open trading window of 2020; and (iii) the remaining third vests on the first open trading window of 2021.\n\nUpon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs were issued to the Reporting Person on February 18, 2018, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and will vest as follows: (i) one-third vests on the first open trading window of 2019; (ii) one-third vests on the date of the first open trading window of 2020; and (iii) the remaining third vests on the first open trading window of 2021.\n\nUpon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A."}],"balance_after":45000,"derivative":{"exercise_price":0,"expiration_date":"2021-03-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-18-005381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924318005381/doc4.xml","form_type":"4"}},{"id":4372815,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-24T22:03:58.000Z","date":"2017-03-22","kind":"grant","acquired":false,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person under the Issuer's Long Term Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-03-21","expiration_date":"2017-03-22","underlying":"Common Stock","underlying_shares":2520},"source":{"system":"sec-edgar","filing":"0000899243-17-008551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317008551/doc4.xml","form_type":"4"}},{"id":4372814,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-24T22:03:58.000Z","date":"2017-03-23","kind":"sale","acquired":false,"shares":750,"price":1.9,"value":1425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."}],"balance_after":271299,"source":{"system":"sec-edgar","filing":"0000899243-17-008551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317008551/doc4.xml","form_type":"4"}},{"id":4372813,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-24T22:03:58.000Z","date":"2017-03-22","kind":"grant","acquired":true,"shares":2520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person under the Issuer's Long Term Incentive Plan."}],"balance_after":272049,"source":{"system":"sec-edgar","filing":"0000899243-17-008551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317008551/doc4.xml","form_type":"4"}},{"id":4425297,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":133334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 14, 2017 and (ii) February 23, 2018."}],"balance_after":266666,"derivative":{"exercise_price":0,"exercise_date":"2017-02-15","expiration_date":"2018-02-23","underlying":"Common Stock","underlying_shares":133334},"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425296,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":48419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on February 22, 2014 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017.  Pursuant to a deferral, the remaining half of the RSUs under this grant will vest on September 13, 2017."}],"balance_after":48418,"derivative":{"exercise_price":0,"exercise_date":"2017-02-15","expiration_date":"2017-09-13","underlying":"Common Stock","underlying_shares":48419},"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425295,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 70,000 RSUs granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on February 15, 2017."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-02-15","expiration_date":"2017-02-15","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425294,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"grant","acquired":false,"shares":7965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person under the Issuer's Long Term Incentive Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-02-15","expiration_date":"2017-02-15","underlying":"Common Stock","underlying_shares":7965},"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425293,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-17","kind":"sale","acquired":false,"shares":6416,"price":1.85,"value":11869.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."}],"balance_after":269529,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425292,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":83900,"price":1.89,"value":158571.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On February 16, 2017, the Reporting Person sold an aggregate of 83,900 shares of the Issuer's Common Stock at a weighted average price of $1.89 per share. The highest sale price for the Common Stock was $1.95 per share and the lowest sale price was $1.85 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":275945,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425291,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":39544,"price":1.95,"value":77110.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On February 15, 2017, the Reporting Person sold an aggregate of 39,544 shares of the Issuer's Common Stock at a weighted average price of $1.95 per share. The highest sale price for the Common Stock was $2.00 per share and the lowest sale price was $1.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":359845,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425290,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":133334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 14, 2017 and (ii) February 23, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 23, 2015 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017. Pursuant to a deferral, the remainder of the RSUs under this grant will vest in equal portions on each of (i) September 14, 2017 and (ii) February 23, 2018."}],"balance_after":399389,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425289,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":48419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on February 22, 2014 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017.  Pursuant to a deferral, the remaining half of the RSUs under this grant will vest on September 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-half of the RSUs granted to the Reporting Person on February 22, 2014 under the Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017.  Pursuant to a deferral, the remaining half of the RSUs under this grant will vest on September 13, 2017."}],"balance_after":266055,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425288,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 70,000 RSUs granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on February 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 70,000 RSUs granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended (the \"Plan\"). Pursuant to a deferral, these RSUs vested on February 15, 2017."}],"balance_after":217636,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4425287,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T23:00:41.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":7965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units (\"RSUs\") granted to the Reporting Person under the Issuer's Long Term Incentive Plan. Pursuant to a deferral, these RSUs vested on February 15, 2017."}],"balance_after":147636,"source":{"system":"sec-edgar","filing":"0000899243-17-005252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317005252/doc4.xml","form_type":"4"}},{"id":4462015,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-02-08T23:04:54.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The RSUs were issued to the Reporting Person on February 6, 2017, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and will vest as follows: (i) one-third vests on the later to occur of March 1, 2018 or the first open trading window of 2018; (ii) one-third vests on the date of the first open trading window of 2019; and (iii) the remaining third vests on the first open trading window of 2020.\n\nUpon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A. The issuance of these RSUs is subject to shareholder approval at the 2017 Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs were issued to the Reporting Person on February 6, 2017, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and will vest as follows: (i) one-third vests on the later to occur of March 1, 2018 or the first open trading window of 2018; (ii) one-third vests on the date of the first open trading window of 2019; and (iii) the remaining third vests on the first open trading window of 2020.\n\nUpon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A. The issuance of these RSUs is subject to shareholder approval at the 2017 Annual Meeting of Stockholders."}],"balance_after":187500,"derivative":{"exercise_price":0,"expiration_date":"2020-03-18","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000899243-17-003155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924317003155/doc4.xml","form_type":"4"}},{"id":4596821,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":26815,"kind":"person","name":"ODONNELL FRANCIS E JR","position":1,"cik":"0001066040","reported_name":"ODONNELL FRANCIS E JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T22:32:43.000Z","date":"2016-09-23","kind":"sale","acquired":false,"shares":50000,"price":2.68,"value":134000.0,"ownership":{"direct":false,"nature":"By HCG II, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 23, 2016, HCGII sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.68 per share. The highest sale price for the Common Stock was $2.81 per share and the lowest sale price was $2.58 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents all of the shares of the Issuer held by HCGII."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII."}],"balance_after":1285490,"source":{"system":"sec-edgar","filing":"0000899243-16-029944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1066040/000089924316029944/doc4.xml","form_type":"4"}}],"next_cursor":"2016-09-23T22:32:43.000000Z,4596821"}